First Header Logo Second Header Logo

Connection

James Pirkle to Botulinum Toxins

This is a "connection" page, showing publications James Pirkle has written about Botulinum Toxins.
Connection Strength

0.865
  1. Wang D, Baudys J, Rees J, Marshall KM, Kalb SR, Parks BA, Nowaczyk L, Pirkle JL, Barr JR. Subtyping botulinum neurotoxins by sequential multiple endoproteases in-gel digestion coupled with mass spectrometry. Anal Chem. 2012 Jun 05; 84(11):4652-8.
    View in: PubMed
    Score: 0.105
  2. Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, Helma CH, Hill K, Kull S, Kirchner S, Dorner MB, Dorner BG, Pirkle JL, Barr JR. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Anal Bioanal Chem. 2012 Apr; 403(1):215-26.
    View in: PubMed
    Score: 0.104
  3. Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernández R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett. 2012 Jan 20; 586(2):109-15.
    View in: PubMed
    Score: 0.102
  4. Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochem. 2011 Nov 15; 12:58.
    View in: PubMed
    Score: 0.101
  5. Parks BA, Shearer JD, Baudys J, Kalb SR, Sanford DC, Pirkle JL, Barr JR. Quantification of botulinum neurotoxin serotypes A and B from serum using mass spectrometry. Anal Chem. 2011 Dec 01; 83(23):9047-53.
    View in: PubMed
    Score: 0.101
  6. Moura H, Terilli RR, Woolfitt AR, Gallegos-Candela M, McWilliams LG, Solano MI, Pirkle JL, Barr JR. Studies on botulinum neurotoxins type /C1 and mosaic/DC using Endopep-MS and proteomics. FEMS Immunol Med Microbiol. 2011 Apr; 61(3):288-300.
    View in: PubMed
    Score: 0.096
  7. Kalb SR, Baudys J, Egan C, Smith TJ, Smith LA, Pirkle JL, Barr JR. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. Appl Environ Microbiol. 2011 Feb; 77(4):1301-8.
    View in: PubMed
    Score: 0.095
  8. Kalb SR, Garcia-Rodriguez C, Lou J, Baudys J, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLoS One. 2010 Aug 17; 5(8):e12237.
    View in: PubMed
    Score: 0.093
  9. Kalb SR, Moura H, Boyer AE, McWilliams LG, Pirkle JL, Barr JR. The use of Endopep-MS for the detection of botulinum toxins A, B, E, and F in serum and stool samples. Anal Biochem. 2006 Apr 01; 351(1):84-92.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.